Literature DB >> 10809953

The role of complement in the acquired immune response.

C H Nielsen1, E M Fischer, R G Leslie.   

Abstract

Studies over the past three decades have clearly established a central role for complement in the promotion of a humoral immune response. The primary function of complement, in this regard, is to opsonize antigen or immune complexes for uptake by complement receptor type 2 (CR2, CD21) expressed on B cells, follicular dendritic cells (FDC) and some T cells. A variety of mechanisms appear to be involved in complement-mediated promotion of the humoral response. These include: enhancement of antigen (Ag) uptake and processing by both Ag-specific and non-specific B cells for presentation to specific T cells; the activation of a CD21/CD19 complex-mediated signalling pathway in B cells, which provides a stimulus synergistic to that induced by antigen interaction with the B-cell receptor (BCR); and promotion of the interaction between B cells and FDC, where C3d-bearing immune complexes participate in intercellular bridging. Finally, current studies suggest that CR2 may also play a role in the determination of B-cell tolerance towards self-antigens and thereby hold the key to the previously observed correlation between deficiencies of the early complement components and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809953      PMCID: PMC2326995          DOI: 10.1046/j.1365-2567.2000.00009.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  107 in total

1.  CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.

Authors:  R H Carter; D T Fearon
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

2.  Complement activation in the follicular light zone of human lymphoid tissues.

Authors:  M Yamakawa; Y Imai
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

3.  The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.

Authors:  L E Bradbury; G S Kansas; S Levy; R L Evans; T F Tedder
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

4.  Somatic mutations in antibodies expressed by germinal centre B cells early after primary immunization.

Authors:  M Apel; C Berek
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

5.  Suppression of the immune response by a soluble complement receptor of B lymphocytes.

Authors:  T Hebell; J M Ahearn; D T Fearon
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

6.  Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3.

Authors:  T K Van den Berg; E A Döpp; M R Daha; G Kraal; C D Dijkstra
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

7.  Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited.

Authors:  A J van den Eertwegh; J D Laman; M M Schellekens; W J Boersma; E Claassen
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

8.  Murine follicular dendritic cells and low affinity Fc receptors for IgE (Fc epsilon RII).

Authors:  K Maeda; G F Burton; D A Padgett; D H Conrad; T F Huff; A Masuda; A K Szakal; J G Tew
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

9.  Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo.

Authors:  G Thyphronitis; T Kinoshita; K Inoue; J E Schweinle; G C Tsokos; E S Metcalf; F D Finkelman; J E Balow
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

10.  Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens.

Authors:  C M Snapper; T M McIntyre; R Mandler; L M Pecanha; F D Finkelman; A Lees; J J Mond
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  23 in total

1.  Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells.

Authors:  Jeong-Hyeon Sohn; Puran S Bora; Hye-Jung Suk; Hector Molina; Henry J Kaplan; Nalini S Bora
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

Review 2.  T-cell stimulation and regulation: with complements from CD46.

Authors:  Claudia Kemper; James W Verbsky; Jeffrey D Price; John P Atkinson
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

5.  Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.

Authors:  Min Pan; QiongXiu Zhou; ShuBei Zheng; XiaoHan You; Duo Li; Ji Zhang; ChaoSheng Chen; FeiFei Xu; ZhanYuan Li; ZhiHong Zhou; JianNa Zhang
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 6.  Production of complement components by cells of the immune system.

Authors:  R Lubbers; M F van Essen; C van Kooten; L A Trouw
Journal:  Clin Exp Immunol       Date:  2017-03-24       Impact factor: 4.330

7.  Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.

Authors:  Laura McCulloch; Karen L Brown; Neil A Mabbott
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

8.  Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase.

Authors:  Chieko Yamamoto; Daisuke Tsuru; Naoko Oda-Ueda; Motonori Ohno; Shosaku Hattori; Sung-Teh Kim
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus.

Authors:  Zhenhua Zhang; Yongqing Li; Shufang Xu; Fuyong Chen; Li Zhang; Beiyu Jiang; Xiaoling Chen
Journal:  Virol J       Date:  2010-05-09       Impact factor: 4.099

10.  A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.

Authors:  Emilian Racila; Brian K Link; Wen-Kai Weng; Thomas E Witzig; Stephen Ansell; Matthew J Maurer; Jian Huang; Christopher Dahle; Ahmad Halwani; Ronald Levy; George J Weiner
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.